Add Company
Join Now

SYSTOLIC Revenue and Competitors

License our Company Data API

Severna Park, MD USA

Location

N/A

Total Funding

Tech Services

Industry

Estimated Revenue & Valuation

  • SYSTOLIC's estimated annual revenue is currently $17.7M per year.(i)
  • SYSTOLIC's estimated revenue per employee is $145,000

Employee Data

  • SYSTOLIC has 122 Employees.(i)
  • SYSTOLIC grew their employee count by 12% last year.

SYSTOLIC's People

NameTitleEmail/Phone
1
Founder, ChairmanReveal Email/Phone
2
VP, RF SystemsReveal Email/Phone
3
VP - Partner DevelopmentReveal Email/Phone
4
VP CNO at SYSTOLIC, Inc.Reveal Email/Phone
5
VP Product StrategyReveal Email/Phone
6
SVP, Chief Partner OfficerReveal Email/Phone
7
Software EngineerReveal Email/Phone
8
Contract Lead/Project Manager/Senior Technical WriterReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$2.8M28-3%N/AN/A
#2
$2.4M24-4%N/AN/A
#3
$1.4M1633%N/AN/A
#4
$2.1M2111%N/AN/A
#5
$8M617%N/AN/A
#6
$1.6M186%N/AN/A
#7
$2.6M260%N/AN/A
#8
$1.7M190%N/AN/A
#9
$1M129%N/AN/A
#10
$1.4M167%N/AN/A
Add Company

What Is SYSTOLIC?

Our mission is to provide the highest quality engineering services to the Intelligence Community (IC) in support of the national defense of the United States of America. SYSTOLIC is founded on integrity, enthusiasm and our relentless dedication to the IC mission. Direct Mission Support Cyber Threat Intelligence Digital Network Intelligence Computer Network Operations Computer Network Defense Computer Network Exploitation Software and Systems Engineering Packet Processing Systems Collection Systems Virtualized and Distributed Architectures Cloud Computing and Analytics Command and Control Data Visualization Digital Signal Processing Systems Software Defined Radio Systems Agile System and Software Development

keywords:N/A

N/A

Total Funding

122

Number of Employees

$17.7M

Revenue (est)

12%

Employee Growth %

N/A

Valuation

N/A

Accelerator

SYSTOLIC News

2022-04-17 - SEISMiC topline results: Istaroxime improves systolic BP ...

Istaroxime is a first-in-class positive inotropic agent designed to improve systolic and diastolic cardiac function by increasing myocardial...

2022-04-17 - Windtree Announces Positive Topline Results from Its Phase 2 SEISMiC Study of Istaroxime in Early Cardiogenic Shock

Istaroxime significantly improved the systolic blood pressure profile. WARRINGTON, Pa., April 20, 2022 (GLOBE NEWSWIRE) -- Windtree...

2022-04-17 - Windtree Therapeutics Sees Positive Results for Istaroxime

The primary endpoint was the difference in systolic blood pressure area under the curve over six hours after initiating the infusion. Secondary...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$45.9M1441%N/A
#2
N/A16634%N/A
#3
N/A16634%N/A
#4
$15M2362%N/A
#5
$105M31117%N/A